Evidence map›Paper›PMID 25051983›Full record

ReviewEndocrine, metabolic & immune disorders drug targets2014

Neutrophil derived microvesicles: emerging role of a key mediator to the immune response.

Bobby L Johnson, Josh W Kuethe, Charles C Caldwell

Abstract readReview
In one paragraph

Review in Endocrine, metabolic & immune disorders drug targets, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Exercise and Circulating Microparticles in Healthy Subjects.Journal of cardiovascular translational research · 2021
    Pooled it
  2. Review
  3. Review
  4. Review
  5. Infection and immunity · 2023
    Article
  6. Review
  7. Review
  8. Review
  9. Role of extracellular vesicles in severe pneumonia and sepsis.Expert opinion on biological therapy · 2022
    Review
  10. Review
  11. Review
  12. Article
  13. Immunological Perspective:Mediators of inflammation · 2022
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Bobby L Johnson
Josh W Kuethe
Charles C CaldwellMSB SRU G479, Cincinnati, OH 45267-0558, USA. charles.caldwell@uc.edu.

Funding

HOST RESPONSE TO TRAUMA RESEARCH TRAINING PROGRAMT32GM008478 · NIGMS · UNIVERSITY OF CINCINNATI · PI TIMOTHY A PRITTS, BASILIA ZINGARELLI · 1993 to 2026
$6.7M
Neutrophil-derived microparticle generation and immune impact during sepsisR01GM100913 · NIGMS · UNIVERSITY OF CINCINNATI · PI CALDWELL, CHARLES C. · 2013 to 2016
$1.2M
NIGMS NIH HHS GM100913-01NIGMS NIH HHS GM8478-20NIGMS NIH HHS R01 GM100913NIGMS NIH HHS T32 GM008478
6 · The paper itself

Abstract

In response to infection and trauma, exquisite control of the innate inflammatory response is necessary to promote an anti-microbial response and minimize tissue injury. Over the course of the host response, activated leukocytes are essential for the initial response and can later become unresponsive or undergo apoptosis. Leukocytes, along the continuum of activation to apoptosis, have been shown to generate microvesicles. These vesicles can range in size from 0.1 to 1.0 μm and can retain proteins, RNA and DNA of their parent cells. Importantly, neutrophil-derived microvesicles (NDMV) are robustly increased under inflammatory conditions. The aim of this review is to summarize the research to date upon NDMVs. This will include describing under which disease states NDMVs are increased, mechanisms underlying formation, and the impact of these vesicles upon cellular targets. Altogether, increased awareness of NDMVs during the host innate response may allow for diagnostic tools as well as potential novel therapies during infection and trauma.

Indexed as

Immunity, InnateAnimalsApoptosisCell CommunicationCell-Derived MicroparticlesHumansLeukocytesNeutrophilsSepsis

Identifiers

PMID25051983
PMCPMC4267953

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.